Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rectal Neoplasms × zimberelimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Cholangiocarcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Oligometastatic Prostate Cancer 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Melanoma 1 Locally Advanced Pancreatic Cancer 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Liposarcoma 1 Gestational Trophoblastic Disease 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoma, Transitional Cell 1 Carcinoma, Neuroendocrine 1

Interventions

Oxaliplatin 129 Fluorouracil 119 Capecitabine 102 Leucovorin 94 Irinotecan 74 Radiotherapy 60 Bevacizumab 56 Cetuximab 39 Folfox protocol 25 Surgical Procedures, Operative 22 Drug Therapy 20 Radiation 18 Panitumumab 17 XELOX 16 Chemotherapy, Adjuvant 15 Neoadjuvant Therapy 14 Chemoradiotherapy 12 Radiotherapy, Intensity-Modulated 11 Floxuridine 9 regorafenib 8 Nivolumab 8 raltitrexed 7 IFL protocol 7 Celecoxib 7 trifluridine tipiracil drug combination 6 aflibercept 6 Trastuzumab 6 Melphalan 6 Immunohistochemistry 6 tislelizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05024097 2025-08-27

PANTHER

Weill Medical College of Cornell University

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡